Blog

PRESS RELEASE: MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication

PRESS RELEASE: MYOS CORP Announces Peer Reviewe...

MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication   Dogs Supplemented with Fortetropin® Experienced Clinically Significant Improvements in Osteoarthritis...

PRESS RELEASE: MYOS CORP Announces Peer Reviewe...

MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication   Dogs Supplemented with Fortetropin® Experienced Clinically Significant Improvements in Osteoarthritis...

PRESS RELEASE: MYOS CORP Announces Positive Results from Feline Study on Fortetropin

PRESS RELEASE: MYOS CORP Announces Positive Res...

Results of Study at University of Florida Form Basis for Company's Entry into Feline Market with Launch of MYOS Feline Muscle Health Formula.   CEDAR KNOLLS, N.J., June 15, 2021 /PRNewswire/ -- MYOS...

PRESS RELEASE: MYOS CORP Announces Positive Res...

Results of Study at University of Florida Form Basis for Company's Entry into Feline Market with Launch of MYOS Feline Muscle Health Formula.   CEDAR KNOLLS, N.J., June 15, 2021 /PRNewswire/ -- MYOS...

PRESS RELEASE: MYOS CORP to Attend VMX In Person, Will Introduce Three Products, Two Clinical Studies, and Vet Advisory Board

PRESS RELEASE: MYOS CORP to Attend VMX In Perso...

Company will share exciting updates with animal health industry leaders at Booth #2442   CEDAR KNOLLS, N.J., June 1, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company...

PRESS RELEASE: MYOS CORP to Attend VMX In Perso...

Company will share exciting updates with animal health industry leaders at Booth #2442   CEDAR KNOLLS, N.J., June 1, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company...

PRESS RELEASE: MYOS CORP Announces Partnership with Animal Health Distribution Leader, Patterson Veterinary

PRESS RELEASE: MYOS CORP Announces Partnership ...

Partnership will allow for scaling of Company's thriving Direct-to-Vet business throughout North America   CEDAR KNOLLS, N.J., March 18, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with...

PRESS RELEASE: MYOS CORP Announces Partnership ...

Partnership will allow for scaling of Company's thriving Direct-to-Vet business throughout North America   CEDAR KNOLLS, N.J., March 18, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with...

PRESS RELEASE: MYOS CORP Announces Formation of Veterinary Advisory Board

PRESS RELEASE: MYOS CORP Announces Formation of...

Seven prestigious thought leaders from private practice and academia will guide MYOS CORP through its next stage of growth in animal health industry. CEDAR KNOLLS, N.J., Feb. 2, 2021 /PRNewswire/ -- MYOS CORP ("MYOS"...

PRESS RELEASE: MYOS CORP Announces Formation of...

Seven prestigious thought leaders from private practice and academia will guide MYOS CORP through its next stage of growth in animal health industry. CEDAR KNOLLS, N.J., Feb. 2, 2021 /PRNewswire/ -- MYOS CORP ("MYOS"...

PRESS RELEASE: MYOS CORP Announces Positive Results from Mobility and Quality of Life Study in Geriatric and Arthritic Dogs at Kansas State University

PRESS RELEASE: MYOS CORP Announces Positive Res...

Dogs Supplemented with Fortetropin® Experienced Statistically Significant Improvements in LOAD (Liverpool Osteoarthritis in Dogs) Scores CEDAR KNOLLS, N.J., Dec. 9, 2020 /PRNewswire/ -- MYOS Corp,a research-based advanced nutrition company with divisions...

PRESS RELEASE: MYOS CORP Announces Positive Res...

Dogs Supplemented with Fortetropin® Experienced Statistically Significant Improvements in LOAD (Liverpool Osteoarthritis in Dogs) Scores CEDAR KNOLLS, N.J., Dec. 9, 2020 /PRNewswire/ -- MYOS Corp,a research-based advanced nutrition company with divisions...